Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
Arega Hovsepyan is our candidate for Chair of the Committee on European IntegrationThe Final Round of the Junius Tournament Has BegunAwards Ceremony for the “Top 100 Students of Armenia” Competition: Presentation of CertificatesNew Samsung Galaxy A27 as Part of Ucom’s Special “Back to School 2026” OfferMillennials, Gen Z, or Gen Alpha: How Different Generations Prepare for the New School Year: Idram&IDBankFinancial Literacy at the Republican Center for Children and Youth Tent Camp: Idram & IDBankUnlocking the Secrets of the Financial World at ''Hayordi'' Camp with Idram&IDBankUcom Supports the Second Phase of ArmDrone’s FPV Drone Educational Program "The Power of One Dram" to "Orran" Charitable Non-Governmental OrganizationUcom and Microsoft Innovation Center’s Cybersecurity Education Program Concludes with a Mini CTF CompetitionCustomer Appreciation Day - This Time at IDBank’s “Erebuni” BranchResults of the Junius Tournament Announced: The Next Round AheadUcom Expands International Roaming Capabilities"Urgently Confirm Your Card Details": IDBank Warns of Hotel Booking ScamsMher Ananyan joins Unibank's Management Board Ucom Supports the Launch of "Remember the Animals" Educational Game Moody’s changes the outlook on IDBank’s ratings to positive IDBank Introduces the New Mastercard World Card with Exclusive Travel Benefits and a Special Launch CampaignConverse Bank and Visa expand their strategic partnership to introduce new customer solutions Ucom and FPWC Ensure Round-the-Clock Wildlife Monitoring in Gnishik Through Solar Energy
All Timeline »
Life

Multiple sclerosis drug shows promising efficacy

The multiple sclerosis drug is showing promising efficacy in fighting relapses and reducing fatigue.

Back in March 2001, the US Food and Drug Administration approved a drug called ponosimod for use in adult patients with various types of multiple sclerosis. Only now there are research data that show that some drug reduces the number of relapses of the disease and can reduce fatigue - one of the characteristic symptoms of multiple sclerosis.

The respected scientific journal JAMA Neurology has found that ponesimod is more effective in fighting fatigue in multiple sclerosis than another commonly used drug called teriflunomide. It is superior to teriflunomide in reducing relapse rates and reducing the risk of new or existing lesions of myelin found on magnetic resonance imaging.

As reported by everydayhealth.com, ponesimod is used for various types of multiple sclerosis, including the most common relapsing remitting disease and active secondary progressive, which is the most severe. It is not accompanied by remissions and steadily leads to the disability of patients. It is people with this form of multiple sclerosis who show the appearance of new lesions of the myelin layer on MRI scans. Ponesimod must be taken once a day, treatment begins with a period of 14 days, then the doses are increased.